Webinar: Impact Funds & Innovations in the Health Sector
ClearlySo has partnered with Octopus Investments and Paul Hastings to launch an online webinar series focused on exploring impact investment funds across asset classes, with the first webinar focused specifically on impact funds and the health sector.
Impact Investment Funds and Innovations in the Health Sector
The webinar showcased how funds in public and private markets are backing emerging new technologies and innovative partnerships that promise to help increase quality of care while reducing costs for health care commissioners and insurers.
Find out more and register for our upcoming webinars in the Impact Investment Funds Webinar Series, series below:
Thomas has been a healthcare investor since 2002. Before joining MVM, he worked at PricewaterhouseCoopers’ Private Equity and Venture Capital practice. Thomas has an MBioch in Molecular and Cellular Biochemistry from Oxford University.
Ed is Investment & Operations Director for Octopus Real Estate, a specialist healthcare infrastructure investor with approximately £1bn of assets under management. He invests in and develops healthcare properties and has considerable experience working with health and care operators and providers, NHS Trusts, CCGs and lenders. He previously acted as an Investment Director on behalf of the Octopus Real Estate-managed MedicX Fund REIT before its £2.3bn merger with Primary Health Properties REIT in March 2019.
Diala Minott is a private funds lawyer at Paul Hastings. She advises on a wide range of fund-related work including activist and impact funds, private equity, private debt, real estate, mezzanine, venture, credit, infrastructure, funds of funds, distressed and special situations funds.
Christoph focuses on investments in life sciences and digital health at Albion VC. He initially practised as a radiologist, before spending 3 years at Bain & Company. In 2006, he joined 3i working for their Healthcare Venture Capital after which he worked for General Electric’s healthcare division, where he was responsible for M&A in the medical technology and healthcare IT sectors. He holds a degree in medicine from Ludwig-Maximilians University, Munich and an MBA from INSEAD.
Rod Schwartz is CEO and Founder of ClearlySo, with a background in equity research, management, investment banking and venture capital. Joining Wall Street in 1980, he rose to become the number one ranked financial services analyst at PaineWebber and then held senior management posts at Lehman Brothers and Paribas, before leaving the sector in 1997 to found the fintech-oriented VC firm Catalyst. A pioneer in the impact investment marketplace, he transformed Catalyst into a social business consultancy, which in 2008 morphed into ClearlySo, a business designed, “to help create 100 Justgivings”. This seemed an exciting new style of company, which achieves significant impact as well as great financial returns.